Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 13/20 | 0.68 |
| ▸ | MMP2 | P08253 | 11/20 | 0.67 |
| ▸ | MMP8 | P22894 | 9/20 | 0.67 |
| ▸ | MMP9 | P14780 | 8/20 | 0.67 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.65 |
| ▸ | ADAM12 | O43184 | 1/20 | 0.65 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.65 |
| ▸ | MMP3 | P08254 | 1/20 | 0.65 |
| ▸ | MMP7 | P09237 | 1/20 | 0.65 |
| ▸ | MMP12 | P39900 | 1/20 | 0.65 |
| ▸ | MMP13 | P45452 | 1/20 | 0.65 |
| ▸ | MMP14 | P50281 | 1/20 | 0.65 |
| ▸ | MMP15 | P51511 | 1/20 | 0.65 |
| ▸ | MMP16 | P51512 | 1/20 | 0.65 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.65 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.65 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.65 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 0.65 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6578096 | 0.90 | MMP2 (0.82) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL851449 | 0.90 | MMP2 (0.82) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL7371076 | 0.89 | ECE1 (0.76) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL6577392 | 0.89 | ECE1 (0.76) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL8271106 | 0.88 | MMP2 (0.70) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL6575485 | 0.87 | MMP1 (0.82) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL7373606 | 0.86 | MMP1 (0.71) | MMP1MMP2MMP8MMP9MMP7 | |
| SCHEMBL13519538 | 0.83 | MMP2 (0.76) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL7412775 | 0.82 | MMP2 (0.84) | MMP1MMP2MMP8MMP9ADAM10 | |
| SCHEMBL5060570 | 0.81 | MMP2 (0.83) | MMP1MMP2MMP8MMP9ADAM10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558648-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-0663823-B1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 2000-11-22 | — | — | EP | disclosed |
| US-5892112-A | ACYLATION OF AMINO ACIDS WITH ANHYDRIDES OR CARBOXY GROUPS, AMIDATION WITH AMINE AND CONVERSION OF ACID OR ESTER TO HYDROXAMIC ACID AND HYDROLYSIS | GLYCOMED INCORPORATED (US) | 1999-04-06 | — | — | US | disclosed |
| US-5773438-A | SKIN DISORDERS, RESTENOSIS, RHEUMATIC ARTHRITIS, WOUND HEALING AGENTS, ANGIOGENESIS, SHOCK | GLYCOMED INCORPORATED (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0558681-B1 | TREATMENT FOR TISSUE ULCERATION | UNIV FLORIDA (US) | 1998-04-08 | — | — | EP | disclosed |
| US-5696147-A | CONTROLLING GROWTH OF TUMORS AND NEOVASCULAR GLAUCOMAS | GLYCOMED, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| EP-0558635-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 1997-09-10 | — | — | EP | disclosed |
| EP-0663823-A4 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0690841-A4 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INC (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0690841-A1 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INCORPORATED (US) | 1996-01-10 | — | — | EP | disclosed |
| EP-0558635-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1993-09-08 | — | — | EP | disclosed |
| EP-0558681-A1 | TREATMENT FOR TISSUE ULCERATION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5239078-A | Collagenase enzyme inhibitors | GLYCOMED INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1993013741-A2 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| US-5189178-A | Preventing protein destruction | GALARDY RICHARD E (US) | 1993-02-23 | — | — | US | disclosed |
| US-5183900-A | Matrix metalloprotease inhibitors | GALARDY RICHARD E (US) | 1993-02-02 | — | — | US | disclosed |
| WO-1992009563-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009556-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009282-A1 | TREATMENT FOR TISSUE ULCERATION | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| US-5114953-A | Peptides | UNIVERSITY OF FLORIDA (US) | 1992-05-19 | — | — | US | disclosed |